Movement disorders in pediatric anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis
Objective: Our aim was to investigate clinical characteristics and evolution of movement disorders (MD) in pediatric anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis. Background: Movement disorders account for…Beliefs about Tourette Syndrome in Adolescent Patients with Tics
Objective: To explore information resources and individual perceptions of causes and modifiers of Tourette Syndrome (TS) and tic disorders. Background: The development of tics is…Mutation screening and burden analysis of AOPEP in dystonia in a Chinese population
Objective: To explore the genetic involvement of AOPEPin dystonia in East Asian population. Background: Recently, AOPEPwas identified to be a novel likely causative gene of autosomal recessive dystonia.…The effect of short-term treadmill exercise in the alpha-synuclein preformed fibril rat model of Parkinson’s disease
Objective: To determine how treadmill exercise impacts behavior and Parkinson-related pathology in the alpha-synuclein (a-syn) preformed fibril (PFF) model. Background: Exercise is often recommended by…Liraglutide once daily versus placebo in Parkinson’s disease: a randomized, double-blind, placebo-controlled trial
Objective: To test safety and efficacy of the glucagon-like peptide 1 (GLP-1) agonist liraglutide in idiopathic Parkinson’s disease (PD). Background: Insulin resistance (IR) may play…Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
Objective: Assess the feasibility of systematic depression screening of people with Parkinson’s (PWP) and determine barriers in the specialist movement disorders setting. Background: While depression…Leading Therapeutic Molecules Target Transcription Factors Binding to Repressor Region in FXN Gene
Objective: To investigate interactions of transcription factors (TFs) binding to repressor region located upstream to FXN gene with leading therapeutic molecules. Background: Low levels of…Fear of progression is predicted by anxiety and self-efficacy but not disease-specific parameters in patients with Parkinson’s disease: data from a multicenter cross-sectional study
Objective: To examine Fear of progression (FoP) prevalence and to analyze FoP predictors in a large Parkinson’s disease (PD) sample. Background: FoP is a reactive…COVID-19-associated antecollis: a case report
Objective: demonstrate a clinical case of antecollis that occurred in a patient after COVID-19 disease. Background: despite numerous studies in favor of the attack of…LFP beta frequency OFF-ON shift in subthalamic nucleus in Parkinson’s disease
Objective: The aim of the current study is to investigate the frequency characteristics of beta activity in Parkinson’s disease. We hypothesized that beta peak central…
- « Previous Page
- 1
- …
- 46
- 47
- 48
- 49
- 50
- …
- 153
- Next Page »